LMAP-21 PRELIMINARY CLINICAL DATA IN THE PHASE 1/2A DOSE ESCALATION TRIAL OF RHENIUM (186RE) OBISBEMEDA (186RNL) IN LEPTOMENINGEAL METASTASES (LM): THE RESPECT-LM TRIAL

OBJECTIVES: Leptomeningeal metastases (LM) are an increasing complication of metastatic cancer with limited treatment options and poor survival. 186RNL is BMEDA-chelated 186Re encapsulated in nanoliposomes. 186Re’s ~2 mm beta emission path length provides direct delivery of radiation therapy while s...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Michael, Bao, Ande, Phillips, William, Hedrick, Marc, Moore, Melissa, LaFrance, Norman, Patel, Toral, Floyd, John, Brenner, Andrew, Michalek, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Local and Multimodality Approaches
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402342/
http://dx.doi.org/10.1093/noajnl/vdad070.052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402342/
http://dx.doi.org/10.1093/noajnl/vdad070.052

Ejemplares similares